/RAMM.CN
RAMM.CN Stock - RAMM Pharma Corp.
Healthcare|Drug Manufacturers - Specialty & GenericCNQ
$0.04+37.50%
+$0.01 (+37.50%) • Dec 22
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.70
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.77
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.04
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RAMM.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.04 – $0.04
TARGET (TP)$0.05
STOP LOSS$0.04
RISK/REWARD1:Infinity
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.07
52W High$0.25
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.34M | $5.07M | $3.90M | $4.12M | $5.44M |
| Gross Profit | $1.76M | $381,820 | $530,505 | $-7,641 | $1.28M |
| Gross Margin | 40.6% | 7.5% | 13.6% | -0.2% | 23.6% |
| Operating Income | $-6,759,794 | $-7,086,145 | $-7,926,931 | $-7,193,257 | $-7,575,792 |
| Net Income | $-16,502,145 | $-7,720,911 | $-20,960,045 | $-7,106,804 | $-7,430,597 |
| Net Margin | -380.1% | -152.4% | -537.8% | -172.7% | -136.5% |
| EPS | $-0.14 | $-0.06 | $-0.17 | $-0.07 | $-0.07 |
Company Overview
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. It offers Epifractán, a cannabinoid pharmaceutical drug; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RAMM.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.10
Q1 2025
EPS Surprise History
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q1 25
No data
Q1 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Mar 31, 2025 | — | $-0.10 | — | — |
Q1 2025 | Jan 31, 2025 | — | $-0.01 | — | — |
Q3 2024 | Sep 27, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 28, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 6, 2024 | — | $-0.02 | — | — |
Q4 2023 | Oct 30, 2023 | — | $-0.03 | — | — |
Q3 2023 | Jul 31, 2023 | — | $-0.01 | — | — |
Q2 2023 | Apr 30, 2023 | — | $-0.01 | — | — |
Q1 2023 | Jan 31, 2023 | — | $-0.01 | — | — |
Q4 2022 | Oct 31, 2022 | — | $-0.13 | — | — |
Q3 2022 | Sep 29, 2022 | — | $-0.01 | — | — |
Q3 2022 | Jul 31, 2022 | — | $-0.01 | — | — |
Q1 2022 | Jan 31, 2022 | — | $-0.02 | — | — |
Q4 2021 | Oct 31, 2021 | — | $-0.02 | — | — |
Q3 2021 | Jul 31, 2021 | — | $-0.03 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Jan 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Oct 31, 2020 | — | $-0.02 | — | — |
Q3 2020 | Jul 31, 2020 | — | $-0.02 | — | — |
Q2 2020 | Apr 30, 2020 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about RAMM.CN
What is RAMM.CN's current stock price?
RAMM Pharma Corp. (RAMM.CN) is currently trading at $0.04 per share. The stock has moved +37.50% today.
What is the analyst price target for RAMM.CN?
No analyst price targets are currently available for this stock.
What sector is RAMM Pharma Corp. in?
RAMM Pharma Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the CNQ exchange.
What is RAMM.CN's market cap?
RAMM Pharma Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does RAMM.CN pay dividends?
No, RAMM Pharma Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCPTR.CN
Captor Capital Corp.
$0.28
Mkt Cap: $0.0B
CRCC.CN
Copland Road Capital Corporation
$0.13
Mkt Cap: $0.0B
OVAT.CN
Ovation Science Inc.
$0.04
Mkt Cap: $0.0B
PBF.CN
Planet Based Foods Global Inc.
$0.07
Mkt Cap: $0.0B
PHA.V
Premier Health of America Inc.
$0.03
Mkt Cap: $0.0B
PHRX.CN
Pharmadrug Inc.
$0.01
Mkt Cap: $0.0B
PSYG.CN
Psyence Group Inc.
$0.12
Mkt Cap: $0.0B
TILT.NE
TILT Holdings Inc.
$0.01
Mkt Cap: $0.0B
VENI.CN
Vencanna Ventures Inc.
$0.01
Mkt Cap: $0.0B
XTRX.CN
Adastra Holdings Ltd.
$0.23
Mkt Cap: $0.0B
Explore stocks similar to RAMM.CN for comparison